PLIANT THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $334.00K, a 25.11% decline year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $3.66M, a 7078.43% increase year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $808.00K, a 15.10% increase year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $446.00K, a 19.89% increase year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $1.36M, a 54.42% decline from fiscal 2021.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $2.98M, a 575.11% increase from fiscal 2020.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $442.00K, a 154.02% increase from fiscal 2019.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $174.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-06-30 | $334.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.66M 10-Q · filed 2023-08-09 | |
| 2022-12-31 | $1.36M 10-K · filed 2023-03-09 | |
| 2022-09-30 | $808.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $446.00K 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $51.00K 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $2.98M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $702.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $372.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.37M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $442.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $177.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $26.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $174.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $14.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $132.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |